Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cavo

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
Leukemia|July 1, 2006
Proteasome inhibitor bortezomib for the treatment of multiple myelomaM Cavo
Hematology/Oncology Clinics of North America|April 1, 1992
Allogeneic bone marrow transplantation in multiple myelomaS Tura, M Cavo
Haematologica|September 1, 1985
Multiple myeloma in young patientsM Cavo, P Galieni, S Tura
Haematologica|October 1, 1982
IgD myeloma in a young womanM Cavo, M Gobbi, C Frejaville
Haematologica|April 1, 1981
Peptichemio in multiple myeloma. (Preliminary results)M Cavo, M Gobbi, S Tura
Drug Metabolism Reviews|January 1, 1976
Formation of stable epoxides in the metabolism of tricyclic drugsA Frigerio, M Cavo-Briones, G Belvedere
Journal of Hematotherapy|August 1, 1996
Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myelomaR M Lemoli, M Cavo, A Fortuna
Expert Review of Hematology|July 14, 2016
Multiple myeloma: disease response assessmentE Zamagni, P Tacchetti, C Terragna, et al.
Bailliere'S Clinical Haematology|December 1, 1995
The role of haematopoietic stem cell-supported myeloablative therapy for the management of multiple myelomaM Cavo, M Benni, A Gozzetti, et al.
Haematologica|October 1, 1979
[Chronic lymphocytic leukemia: prognostic factors and stage classification (author's transl)]M Baccarani, M Gobbi, M Cavo, et al.
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Leukemia|July 1, 2006
Proteasome inhibitor bortezomib for the treatment of multiple myelomaM Cavo
Hematology/Oncology Clinics of North America|April 1, 1992
Allogeneic bone marrow transplantation in multiple myelomaS Tura, M Cavo
Haematologica|September 1, 1985
Multiple myeloma in young patientsM Cavo, P Galieni, S Tura
Haematologica|October 1, 1982
IgD myeloma in a young womanM Cavo, M Gobbi, C Frejaville
Haematologica|April 1, 1981
Peptichemio in multiple myeloma. (Preliminary results)M Cavo, M Gobbi, S Tura
Drug Metabolism Reviews|January 1, 1976
Formation of stable epoxides in the metabolism of tricyclic drugsA Frigerio, M Cavo-Briones, G Belvedere
Journal of Hematotherapy|August 1, 1996
Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myelomaR M Lemoli, M Cavo, A Fortuna
Expert Review of Hematology|July 14, 2016
Multiple myeloma: disease response assessmentE Zamagni, P Tacchetti, C Terragna, et al.
Bailliere'S Clinical Haematology|December 1, 1995
The role of haematopoietic stem cell-supported myeloablative therapy for the management of multiple myelomaM Cavo, M Benni, A Gozzetti, et al.
Haematologica|October 1, 1979
[Chronic lymphocytic leukemia: prognostic factors and stage classification (author's transl)]M Baccarani, M Gobbi, M Cavo, et al.
Pageof 15